2 recruiting, 1 not yet recruiting, 1 terminated. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 2, Not yet recruiting 1, Terminated 1 |
Follow Myelodysplastic Syndromes (MDS): new trials by email Literature Review of Myelodysplastic Syndromes (MDS) trials Research Report on Myelodysplastic Syndromes (MDS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML Mitoxantrone Hydrochloride Liposome, Cytarabine, Granulocyte Colony-Stimulating Factor(G-CSF) - Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) | Phase 3 | Not yet recruiting | Ruijin Hospital | 168 | 2026-07-30 | 2026-07-29 |
| Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation Ivosidenib, Azacitidine - Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS) | Phase 3 | Recruiting | Institut de Recherches Internationales Servier | 48 | 2024-12-03 | 2026-09-03 |
| A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials Luspatercept - Myelodysplastic Syndromes (MDS), Beta-thalassemia | Phase 3 | Recruiting | Celgene | 665 | 2019-08-12 | 2026-07-01 |
| Panobinostat Maintenance After HSCT fo High-risk AML and MDS Panobinostat - Acute Myeloid Leukaemia (AML), Myelodysplastic Syndromes (MDS) | Phase 3 | Terminated | Goethe University | 52 | 2018-07-24 | 2023-02-16 |
Myelodysplastic Syndromes (4) · Leukemia, Myeloid, Acute (2) · Myeloproliferative Disorders (1) · beta-Thalassemia (1)
Bone Marrow Diseases (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia (2) · Leukemia, Myeloid (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hemoglobinopathies (1) · Thalassemia (1)
Azacitidine (2) · Cytarabine (1) · Panobinostat (1) · ivosidenib (1) · luspatercept (1) · venetoclax (1)
Celgene (1) · Goethe University (1) · Institut de Recherches Internationales Servier (1) · Ruijin Hospital (1)
Germany (3) · Netherlands (3) · Australia (2) · France (2) · Italy (2) · Japan (2) · Spain (2) · United Kingdom (2) · United States (2) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · China (1) · Greece (1)
Gesine Bug, PD Dr. (1) · Sujiang Zhang (1)
2023 (1)